Company Overview
CATALYST PHARMACEUTICALS, INC.
CPRXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
589M
2025 FY
Net Income
214M
2025 FY
Shares Outstanding
122M
2025 FY
EPS
1.75USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1369568
Exchange
Nasdaq
Location
US